Boston Scientific's Innova peripheral stent débuts in Europe | Regulatory Roundup

May 15, 2012 by MassDevice staff

Boston Scientific, CE Mark in hand, says it plans to get its Innova peripheral vascular stent on the market immediately; also, Health Canada warns on metal-on-metal hip implants; U-Systems wins FDA approvable letter for breast ultrasound PMA; Maquet lands 510(k) for new aortic balloon catheter sizes; and more.

MassDevice.com news

Boston Scientific (NYSE:BSX) said it plans to get its Innova stent for peripheral artery disease on the market in the European Union "immediately" now that it's won CE Mark approval there.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp